Notes
Including CLARITY (NCT00213135), CLARITY extension (NCT00641537), ORACLE MS (NCT00725985), ONWARD (NCT00436826), and PREMIERE (NCT01013350).
Reference
Giovannoni G, et al. Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety. Drug Safety : 23 May 2020. Available from: URL: http://doi.org/10.1007/s40264-020-00948-x
Rights and permissions
About this article
Cite this article
Pregnancy outcomes with cladribine in multiple sclerosis. Reactions Weekly 1807, 9 (2020). https://doi.org/10.1007/s40278-020-79295-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-79295-y